Skip to main
DLB

Dolby Laboratories (DLB) Stock Forecast & Price Target

Dolby Laboratories (DLB) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

Dolby Laboratories Inc. recorded a 1.6% year-over-year increase in product and service revenue, driven by stronger-than-expected growth fueled by the timing of deal closures. The company's strategic focus on expanding its Premium Large Format (PLF) cinema concept and the growing adoption of technologies such as Atmos and Vision has positioned it for significant revenue increases, particularly in licensing, which constitutes nearly half of the total revenues. Additionally, Dolby Laboratories aims to enhance future growth through innovative SaaS-like models related to patent licensing and its OptiView solution, setting a strong foundation for sustained financial performance.

Bears say

Dolby Laboratories Inc. is facing a negative outlook due to expected declines in key revenue categories, with a projected 7.5% year-over-year decrease in licensing revenue and a 5.7% drop in products and services for the December quarter. Additionally, operating expenses are anticipated to increase by 5.5% year-over-year, exacerbating the company's profitability challenges as gross margins decreased from 90.8% to 89.8%. Further complicating the financial landscape, the company is anticipating a similar high-single-digit revenue decline for fiscal 2026, mirroring the downturn experienced in fiscal 2025, as overall expectations in the PC and consumer electronics markets remain weak.

Dolby Laboratories (DLB) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Dolby Laboratories and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Dolby Laboratories (DLB) Forecast

Analysts have given Dolby Laboratories (DLB) a Buy based on their latest research and market trends.

According to 4 analysts, Dolby Laboratories (DLB) has a Buy consensus rating as of Mar 17, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $90.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $90.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Dolby Laboratories (DLB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.